Stellungnahmen

Was denken die Kostenträger über den neuesten HTA-Vorschlag?

AIM begrüßt Bemühungen auf EU-Ebene, die Qualität und Aktualität von Gesundheitstechnologiebewertungen zu verbessern. Es ist hervorragend, durch eine unionsweite Zusammenarbeit sicherzustellen, d......

15.02.2018 - Mehr

AIM publishes position on TFAs

AIM answered the open public consultation on the initiative to limit industrial trans fats intakes in the EU. On that occasion the organisation also published a position paper: TFApositionpaper as......

22.01.2018 - Mehr

AIM members have different roles in ensuring access to pharmaceuticals

AIM discusses during its general assembly what could be appropriate steps towards sustainable access to pharmaceuticals. But why should AIM members be involved in those discussions? Are payers not jus......

09.11.2017 - Mehr

We know what FAIR is!

The Dutch Minister of Health, Mrs Edith Schippers, brought the topic to the agenda of the European Council last year. The Commission is now trying to find out whether she had a point, whether it is tr......

11.10.2017 - Mehr

Press release: Dialogue between EMA and AIM

The AIM Working Group on Pharmaceuticals participated last week in London, at the European Medicines Agency (EMA) in a dialogue between EMA and payer organisations about how to ensure alignment of eff......

27.09.2017 - Mehr

Care integration offers opportunities for AIM members to steer necessary change in health delivery

On 30 June, the International Association for Mutual Benefit Societies organised in Antwerp a seminar on integrated care. This discussion was organised to present what AIM members and other organisati......

30.06.2017 - Mehr - Download
1 2 3 4 5 6